camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'repare therap', 'repare,(-prepare)']
$rptx repare therapeutics presents initial clinical data from the phase 1/2 tresr and attacc trials evaluating camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting #investing #trading
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i